EUVIMEDEUVIMED entdecken
Crossref

Individualized Family Screening for Arrhythmogenic Right Ventricular Cardiomyopathy

Steven A Muller, Alessio Gasperetti, Laurens P Bosman, Amand F Schmidt, Annette F Baas, Ahmad S Amin, Arjan C Houweling, Arthur A M Wilde, Paolo Compagnucci, Mattia Targetti, Michela Casella, Leonardo Calò und 6 weitere

Journal of the American College of Cardiology · 2023-07 · 82 (3) · 214-225

DOI: 10.1016/j.jacc.2023.05.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American College of Cardiology, 2023-07. Verfasst von Steven A Muller und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands; Netherlands Heart Institute, Utrecht, the Netherlands. Hauptthemen laut MEDLINE: Arrhythmogenic Right Ventricular Dysplasia. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Department of Health, British Heart Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Clinical guidelines recommend regular screening for arrhythmogenic right ventricular cardiomyopathy (ARVC) to monitor at-risk relatives, resulting in a significant burden on clinical resources. Prioritizing relatives on their probability of developing definite ARVC may provide more efficient patient care. OBJECTIVES: The aim of this study was to determine the predictors and probability of ARVC development over time among at-risk relatives. METHODS: A total of 136 relatives (46% men, median age 25.5 years [IQR: 15.8-44.4 years]) from the Netherlands Arrhythmogenic Cardiomyopathy Registry without definite ARVC by 2010 task force criteria were included. Phenotype was ascertained using electrocardiography, Holter monitoring, and cardiac imaging. Subjects were divided into groups with "possible ARVC" (only genetic or familial predisposition) and "borderline ARVC" (1 minor task force criterion plus genetic or familial predisposition). Cox regression was performed to determine predictors and multistate modeling to assess the probability of ARVC development. Results were replicated in an unrelated Italian cohort (57% men, median age 37.0 years [IQR: 25.4-50.4 years]). RESULTS: At baseline, 93 subjects (68%) had possible ARVC, and 43 (32%) had borderline ARVC. Follow-up was available for 123 relatives (90%). After 8.1 years (IQR: 4.2-11.4 years), 41 (33%) had developed definite ARVC. Independent of baseline phenotype, symptomatic subjects (P = 0.014) and those 20 to 30 years of age (P = 0.002) had a higher hazard of developing definite ARVC. Furthermore, patients with borderline ARVC had a higher probability of developing definite ARVC compared with those with possible ARVC (1-year probability 13% vs 0.6%, 3-year probability 35% vs 5%; P 0.05). CONCLUSIONS: Symptomatic relatives, those 20 to 30 years of age, and those with borderline ARVC have a higher probability of developing definite ARVC. These patients may benefit from more frequent follow-up, while others may be monitored less often.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arrhythmogenic Right Ventricular DysplasiaHumansElectrocardiographyPhenotypeNetherlands

Stichwörter der Autor:innen

ARVCfamily screeningpredictorsscreening intervalventricular arrhythmia

Autor:innen und Institutionen

  • Department of Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands; Netherlands Heart Institute, Utrecht, the Netherlands.
  • Department of Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands; Division of Medicine, Department of Cardiology, Johns Hopkins University, Baltimore, Maryland, USA; Department of Clinical Electroph…
  • Department of Cardiology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Institute of Cardiovascular Science, Faculty of Population Health Sciences, University College London, London, United Kingdom; Amsterdam University Medical Centers, Department of Cardiology, University of Amsterdam, Ams…
  • Department of Genetics, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Amsterdam University Medical Centers, Department of Cardiology, University of Amsterdam, Amsterdam, the Netherlands.

Förderung

  • Department of Health
  • British Heart Foundation

Zitieren

APA

Muller, S. A., Gasperetti, A., Bosman, L. P., Schmidt, A. F., Baas, A. F., Amin, A. S., Houweling, A. C., Wilde, A. A. M., Compagnucci, P., Targetti, M., Casella, M., Calò, L., Tondo, C., van der Harst, P., Asselbergs, F. W., van Tintelen, J. P., Oerlemans, M. I. F. J., & Te Riele, A. S. J. M. (2023). Individualized Family Screening for Arrhythmogenic Right Ventricular Cardiomyopathy. Journal of the American College of Cardiology, 82(3), 214-225. https://doi.org/10.1016/j.jacc.2023.05.005

Vancouver

Muller SA, Gasperetti A, Bosman LP, Schmidt AF, Baas AF, Amin AS, et al. Individualized Family Screening for Arrhythmogenic Right Ventricular Cardiomyopathy. Journal of the American College of Cardiology. 2023;82(3):214-225. doi:10.1016/j.jacc.2023.05.005

BibTeX
@article{Muller2023,
  author = {Muller, Steven A and Gasperetti, Alessio and Bosman, Laurens P and Schmidt, Amand F and Baas, Annette F and Amin, Ahmad S and Houweling, Arjan C and Wilde, Arthur A M and Compagnucci, Paolo and Targetti, Mattia and Casella, Michela and Calò, Leonardo and Tondo, Claudio and van der Harst, Pim and Asselbergs, Folkert W and van Tintelen, J Peter and Oerlemans, Marish I F J and Te Riele, Anneline S J M},
  title = {Individualized Family Screening for Arrhythmogenic Right Ventricular Cardiomyopathy},
  journal = {Journal of the American College of Cardiology},
  year = {2023},
  volume = {82},
  number = {3},
  pages = {214--225},
  doi = {10.1016/j.jacc.2023.05.005}
}
Kostenlos starten →